Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists |
Mechanism 5-HT2B receptor antagonists(Serotonin 2b (5-HT2b) receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pulmonary Arterial Hypertension | Preclinical | China | 27 Apr 2021 | |
| Pulmonary Disease, Chronic Obstructive | Preclinical | China | 27 Apr 2021 |





